)

eXoZymes (EXOZ) investor relations material
eXoZymes Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Focused on developing high-value natural products and nutraceuticals with pharmaceutical potential, leveraging proprietary cell-free biomanufacturing and AI-driven enzyme engineering for rapid, efficient R&D cycles.
Achieved key scientific and business milestones, including gram-scale NCT production in five months with 96% yield and over 99% purity, and launched Santalini as a new candidate.
Completed IPO in November 2024, raising $15.2M net proceeds, and continues to rely on grants and equity for funding.
Strategic shift to brand building with 'powered by exosomes' platform, aiming for industry standardization and expanded partnerships.
Substantial doubt remains about ability to continue as a going concern due to ongoing losses and pre-revenue status, despite sufficient near-term working capital.
Financial highlights
Net loss for Q2 2025 was $2.36M; year-to-date net loss reached $4.22M, up 78% year-over-year.
Operating expenses rose by $1.2M year-over-year to $2.55M in Q2, and by 92.5% to $4.5M for the first half of 2025, mainly due to R&D and personnel expansion.
Cash and cash equivalents were $6.99M as of June 2025, supporting operations into 2026.
$1.4M in grant income recognized through Q2; $3M CFIRE/NSF grant not yet fully incorporated into cash flow.
No revenue recognized; operations funded by grants, IPO proceeds, and equity issuances.
Outlook and guidance
Continued focus on nutraceuticals with pharmaceutical potential, aiming for first licensing partner announcement soon.
Management believes current working capital is sufficient for near-term operations but anticipates need for additional funding for long-term obligations.
Ongoing pursuit of non-dilutive funding, strategic partnerships, and government grants, especially from the Department of Defense.
Plans to expand investor outreach via non-deal roadshows and engagement with top investment banks.
Ongoing dedication to developing high-value natural products and next-generation biomanufacturing.
Next eXoZymes earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage